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Abstract
Problem: Opioid use and misuse is a leading cause of injury and death among adolescents and
young adults in the United States, with a three-fold increase in opioid overdoses since 2000
(Carney et al., 2018; Hudgins et al., 2019). Opioid misuse correlates with misuse of other
substances, which exponentially increases health risks over time. The most effective treatment
for opioid use disorder (OUD) among adolescence is through effective prevention interventions
that either prevent the development of the OUD or enable timely diagnosis and treatment in
order to prevent poor health outcomes.
Context: The use of eHealth technology, which has been successfully used in the management
of other chronic diseases, including hypertension and diabetes mellitus, is one proposed
intervention to prevent OUD among youth and to connect them with treatment resources
(Nuamah et al., 2020). This technology could be particularly useful among youth due to their
familiarity with and affinity towards using technology in their everyday lives. Granite Wellness
Centers (GWC), a drug and alcohol treatment organization in rural Northern California,
received grant funding from The California Youth Opioid Response (YOR California), to
design and develop an eHealth resource to address OUD among youth ages 12 years to 24
years in rural Northern California communities (California Institute for Behavioral Health
Solutions, 2015). This project sought to design and develop an eHealth resource and to conduct
a pilot program.
Interventions: A youth focus group and online survey were conducted to gather stakeholder
data and input regarding the design for the eHealth drug resource. The stakeholder data
informed the design and development of the GWConnect mobile app, to include culturallyinformed harm reduction tools, such as unbiased, evidence-based drug information; news
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alerts; ask-a-provider feature; and local treatment resources. An 80-day pilot program was
conducted to assess effectiveness of the app.
Outcome Measures: A pre/post pilot survey was administered to assess change in youth
knowledge of drugs, knowledge of local drug treatment resources, and the likelihood that youth
would use the app to access information on drugs and local treatment resources. The surveys
also assessed whether youth found the app to be effective in delivering the aforementioned
content and their level of satisfaction with the app.
Results: Through data analysis, results indicated a 26.47% increase in knowledge about drugs
and a 20.32% increase in likelihood youth would use a mobile app to access information on
drugs. Interestingly, even though the greatest increase was observed in knowledge of drug
treatment resources and how to access them (45.83%), there was only a slight increase in the
likelihood youth would use a mobile app to access information on treatment resources
(14.09%). Overall, the pilot program participants were satisfied with GWConnect and found it
to be effective.
Conclusions: Increased knowledge can empower youth to make informed decisions preventing
substance use disorder and/or reducing harm related to risky behaviors Increased knowledge of
treatment resources can improve timeliness of treatment initiation and reduce harm associated
with untreated substance use disorder. The overarching aim of GWConnect is to reduce the
incidence of OUD and overdoses among rural youth in Northern California; therefore, future
longitudinal research is needed to assess its effectiveness over a period of time.
Keywords: Opioid use disorder/OUD, prevention, treatment, youth, adolescents, mobile
application, mobile app, app, eHealth resource, and eHealth technology.
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Section II: Introduction
Background
The opioid class of drugs includes prescription pain relievers, such as oxycodone,
hydrocodone, morphine, and codeine; synthetic opioids, such as fentanyl; and illicit opioids, such
as heroin (National Institute on Drug Abuse, 2020). Initially, prescription opioids were mainly
used to treat cancer pain and acute pain, dating back to 1911 (U.S. Food and Drug
Administration (FDA), Center for Drug Evaluation and Research, 2021).
Misuse of opioids refers to any use other than how they are prescribed or the use of illicit
opioids in any way. Misuse of opioids increases the risk of overdose and death, and widespread
misuse has results in an opioid overdose epidemic that has plagued the United States for over
three decades (Centers for Disease Control and Prevention [CDC], 2021a). The opioid epidemic
can be described by three distinct waves, periods of time in which significant spikes in opioid
overdose deaths have been observed in the United States (CDC, 2021a).
The first wave of the opioid epidemic in the United States occurred in the 1990s, when
there was an increase in opioid prescriptions and an increase in overdose deaths involving
prescription opioids (CDC, 2021a). Several events preceded and contributed to the first wave. In
the 1980s, two small retrospective studies, published by the New England Journal of Medicine
and the Pain Journal, reassured medical providers that it was safe to prescribe opioids more
frequently (Jones et al., 2018). Pharmaceutical companies then aggressively marketed opioids as
non-addictive (Jones et al., 2018). In 1996, pain was added as the fifth vital sign. As a result,
there was an increased priority placed on assessing and treating pain thoroughly and in a timely
manner (Levy et al., 2018). Consequently, the threshold for administering prescription opioids
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for the treatment of pain was lowered, and medical professionals began prescribing opioids more
frequently (Scalpel, 2016).
The second wave occurred in 2010, approximately two decades after the first wave, when
there was an increase in overdose deaths involving the illicit opioid heroin (CDC, 2021a).
Decades of overprescribing opioids resulted in an increase in the number of people who
developed a physical dependence to opioids, which would result in withdrawal symptoms if they
stopped taking these medications (Jones et al., 2018). This opioid-dependent population also
developed a higher tolerance over time that required more opioids to achieve the same effect. As
a result, if unable to obtain enough prescription opioids to meet their physical dependence and
prevent withdrawal symptoms, people began to seek out and use illicit opioids, such as heroin or
any opioids obtained on the street without a prescription (CDC, 2021a). Consequently, there was
an increase in heroin overdose deaths in 2010 (CDC, 2021a).
The third wave occurred in 2013, a few years after the second wave, when there was an
increase in overdose deaths involving synthetic opioids, particularly fentanyl (CDC, 2021a). The
demand for fentanyl has remained high to the present day. Fentanyl is found in combination with
other substances, rendering it exponentially more dangerous (CDC, 2021a).
An opioid use disorder (OUD), encompassing misuse and abuse of opioids, is a high-risk
behavior that has been noted to result in increased crime, utilization of health care services, and
disease transmission, as well as lost productivity and strained personal relationships (Timko et
al., 2016). There has been a significant societal impact related to the opioid crisis, in addition to
the increased costs that society has absorbed due to lost employment, criminal justice utilization,
healthcare services, and fatal opioid overdoses (Hagemeier, 2018). In 2015, it was estimated that
the total annual economic burden of the opioid crisis was $504 billion (Hagemeier, 2018).
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As well as the financial cost, OUD increases an individual’s morbidity and mortality risk
by increasing the risk of drug overdose, cardiovascular disease, cancer, and infectious diseases,
such as Hepatitis C (Hser et al., 2017). In the United States in 2016, there were 64,000 deaths
due to drug overdoses, with 66% of those due to opioids (Jones et al., 2018). From 1999 to 2014,
fatal opioid overdoses tripled among young people ages 15 years to 24 years (Saloner et al.,
2017). The U.S. Department of Health and Human Services (2019) classified the opioid
epidemic as a public health emergency in 2017.
The Problem: Adolescents and Opioid Use
Substance use is often initiated during adolescence (National Institute on Drug Abuse,
2020). From 1994 to 2007, the prescribing rates for prescription opioids among adolescents and
young adults doubled (American Society of Addiction Medicine, 2016). However, adolescents in
the United States are at high risk of being exposed to and becoming dependent upon opioids for
many additional reasons, including, but not limited to, ready access, a developing and vulnerable
state of mind, peer pressure, and engagement in risky behaviors (National Institute on Drug
Abuse, 2020).
Monitoring the Future study surveys a cross-sectional, nationally representative sample
of high school seniors in the United States on an annual basis, and the prevalence data indicated
that prescription opioid use increased steadily from 1976, with peaks in 1989 and 2002 and a
brief decline from 2013 to 2015 (McCabe et al., 2017). Twenty-five percent of high school
seniors reported opioid use (McCabe et al., 2017). Adolescents who reported non-medical opioid
use indicated they initially started with medical opioid use (McCabe et al., 2017).
In 2015 and 2016, The National Survey on Drug Use and Health revealed that in the
United States, 21% of adolescents (12 years to 17 years) and 32% of young adults (18 years to
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25 years) used prescription opioids in the past year, and 4% of adolescents and 8% of young
adults misused opioids (Hudgins et al., 2019). In 2016, the prevalence of adolescents who
misused opioids in California was 7%, which is 3% higher than the national average, with higher
rates observed in rural California communities, primarily due to limited resources (Regents of
the University of California, 2020).
The National Institute on Drug Abuse for Teens (2019) reported that 57% of 12- to 17year-olds who misused prescription opioids got them from a friend or relative, while 20% of 12th
graders said they could get heroin if they so desired. In 2015, 21,000 adolescents in the United
States reported using heroin (American Society of Addiction Medicine, 2016).
In 2015, 276,000 adolescents were using opioids for non-medical reasons, and 44% of
those individuals were diagnosed with an addiction to opioids (American Society of Addiction
Medicine, 2016). Opioid use and misuse is a leading cause of injury and death among
adolescents and young adults in the United States (Hudgins et al., 2019). Most youth who misuse
prescription opioids obtained them from a single prescriber, friends, or a family member. Opioid
misuse also correlates with misuse of other substances, which exponentially increases health
risks over time.
Treatment programs that incorporate both pharmacotherapy and biopsychosocial
interventions have proven to be the most effective treatment for opioid dependence (Jones et al.,
2018). The preferred treatment delivery method for anyone, adolescent or adult, with an OUD is
medically-assisted treatment (MAT), because it takes a holistic approach by incorporating
medication, behavioral therapy, and psychosocial supports, and it correlates with better patient
outcomes (Timko et al., 2016). According to the Substance Abuse and Mental Health Services
(SAMSHA, 2015), MAT programs have been shown to improve patient survival, increase
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retention in treatment, decrease illicit opiate use, decrease criminal activity, increase ability to
secure and maintain employment, improve birth outcomes for moms with OUD, decrease risk of
contracting the human immunodeficiency virus (HIV) and Hepatitis C, and decrease risk of
relapse.
The opioid crisis has significantly impacted adolescents, with a three-fold increase in
opioid overdoses since 2000 (Carney et al., 2018). However, only about 8.5% of adolescents
with OUD receive treatment (Carney et al., 2018). Carney et al. (2018) presented treatment
protocols for adolescents with OUD based upon evidence-based research. The medication aspect
of MAT includes prescription medications approved by the FDA to treat OUD. These
medications include buprenorphine/naloxone, methadone, and naltrexone.
Buprenorphine is a partial opioid agonist that diminishes opioid withdrawal symptoms,
reduces cravings, increases safety in the event of an opioid overdose, and has a low potential for
misuse and diversion (SAMSHA, 2015). Buprenorphine is also available in combination with
naloxone, the rescue medication used to treat opioid overdose. Methadone is a full opioid agonist
that reduces opioid cravings and withdrawal symptoms and blocks the effects of opioids
(SAMHSA, 2015). Naltrexone is a competitive opioid receptor antagonist that blocks the
euphoric and sedative effects of opioids and reduces opioid cravings. Naltrexone is not addictive
and does not cause withdrawal symptoms when it is discontinued (SAMHSA, 2015). Carney et
al. (2018) recommended that primary care providers become familiar with the prescribing
practices of these medications in order to better serve adolescents with OUD, especially in
settings with limited resources, such as rural areas.
The medications to treat OUD have been well-studied and approved for use in adults, but
little research has been done on their use among youth because the prevalence of OUD among
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youth has only recently been identified as a significant problem (Camenga et al., 2019).
Camenga et al. (2019) conducted a literature review of 14 published works on methadone,
buprenorphine, and naltrexone to obtain efficacy data among adolescents. They found that the
risk of not treating OUD outweighs the risk associated with any of the medications.
Chang et al. (2018) proposed treatment protocols for adolescents and young adults (15
years to 25 years) with OUD based upon evidence-based research. Buprenorphine/naloxone is
currently approved for use in 16-year-olds. Methadone can be prescribed under the age of 18
years, but parental consent or evidence of failed abstinence or difficulty with withdrawing from
opioids may be required (Chang et al., 2018). Buprenorphine/naloxone is safe for use among
youth with OUD and should be considered first-line treatment. The American Academy of
Pediatrics and other agencies have expressed their support of buprenorphine/naloxone and
methadone for treatment of youth with OUD because the benefits of treating OUD with these
medications appear to outweigh the risks of potential medication side effects (Chang et al.,
2018).
Even though there is limited data to demonstrate efficacy of these medications in
adolescents, anecdotal and practice-based evidence demonstrates better health outcomes (Chang
et al., 2018). A recent study demonstrated that prolonged use of the aforementioned medications
was effective in preventing relapse (Chang et al., 2018). Youth reported that buprenorphine/
naloxone was superior to methadone in reducing cravings and withdrawal symptoms (Chang et
al., 2018).
Another important factor youth reported was they perceived less stigma associated with
buprenorphine/naloxone versus methadone. Stigma and shame are contributing factors as to why
individuals with OUD do not seek treatment (Carson, 2019). Carson (2019) utilized theoretical
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principles to better understand how medical providers may increase barriers to treatment for
adolescents with OUD based upon their own unconscious biases. The article addresses the
phenomena that many healthcare providers place a stigma on OUDs, which prevents them from
discussing and initiating treatment, even life-saving measures such as naloxone. Medical
providers ought to be aware of any unconscious biases they may have that can lead to
stigmatizing OUD and that may have negative implications on their ability to discuss the realities
of an OUD with their patients.
Buprenorphine/naloxone can be prescribed by any approved provider in any setting;
whereas, methadone must be prescribed, dispensed, and monitored with frequent follow-up visits
by a methadone clinic (Chang et al., 2018). As a result of the findings in the Chang et al. (2018)
study, the use of buprenorphine/naloxone is considered first-line treatment for adolescents with
OUD; methadone is considered second-line treatment.
Naltrexone is the third FDA-approved medication to treat OUD. Naltrexone carries a
potentially serious side effect of increased risk of fatal overdose in the event of a relapse because
the medication reduces one’s opioid tolerance. For example, if someone taking naltrexone
relapses and uses the same amount of opioids they were accustomed to using prior to starting
naltrexone, they could die from an unintentional fatal overdose due to their decreased opioid
tolerance (Chang et al., 2018). Relapse is a common phase in the cycle of any chronic condition,
including addiction; therefore, every person should receive extensive counseling on this potential
side effect prior to starting the medication (American Addiction Centers, 2019). The extendedrelease formulation of naltrexone may carry less risk of fatal overdose because it is released into
the body at a slow rate; further studies are needed on its use among adolescents.
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In addition to the medications, the psychosocial supports are the other aspect of MAT and
are recommended during all stages of treatment (Chang et al., 2018). Psychosocial supports
include various forms of individual, group, and/or family counseling and behavioral therapies.
Feder et al. (2017) conducted an observational study and analyzed data from the 2013
Treatment Episode Data Set to quantify adolescents’ current use of MAT. They found that about
26% of adults in treatment for heroin addiction receive MAT services, compared to only about
2% of adolescents. The reasons for adolescent underutilization of MAT are not well understood,
because MAT has not been widely studied among adolescents, but patient, parent, and physician
preferences are thought to be contributing factors (Feder et al., 2017). Another barrier is that,
despite the dramatic rise in the prevalence of OUD among youth, medical providers, particularly
pediatricians and primary care providers, have not received adequate training in addiction
treatment and have not established connections within their communities to readily and
efficiently refer patients to MAT programs (Feder et al., 2017).
Hadland et al. (2018) reported that the initiation of medication to treat OUD at the time of
diagnosis results in better health outcomes due to improved retention in treatment compared to
the initiation of psychosocial interventions alone. The aforementioned medications approved to
treat OUD primarily do so by reducing cravings and withdrawal symptoms and blocking or
blunting the effects of opioids (SAMHSA, 2015). However, Hadland found that only 25% of
young adults (18 years to 22 years) and only 4.5% of adolescents (18 years and younger) were
prescribed medications to treat OUD at time of diagnosis. Adolescents are not receiving the full
spectrum of OUD treatment.
The most effective treatment for OUD among adolescents is through effective prevention
interventions that either preclude the development of the OUD or enable timely diagnosis and
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treatment in order to prevent poor health outcomes. Screening for risk factors during adolescence
and taking steps to better understand social determinants of health is necessary to identify
barriers that delay diagnosis and treatment, as well as treatment retention (Grubb, 2019).
Education, or lack thereof, may be an important barrier to assess. Schepis et al. (2018) conducted
a cross-sectional study utilizing data from the 2015 National Survey on Drug Use and Health and
found that the highest rates of misuse were observed among individuals who were poorly
engaged in school or not in school at all. Another barrier may be current policies that limit access
or impose certain processes that make it difficult to gain access to proper evaluation and
treatment; policy change is needed to expand access and facilitate ease of referral to MAT
services for adolescents (Feder et al., 2017). This DNP project sought to research and develop an
innovative harm reduction resource to address opioid use among youth in rural Northern
California.
Specific Aims
The overarching aim is to reduce the incidence of OUD and overdose among rural youth
in Northern California. The project goal is the development and implementation of an eHealth
intervention by May 2021 that will provide culturally-informed harm reduction tools (e.g.,
unbiased drug information, Narcan information, news alerts, ask-a-provider feature, and referral
resources) to reduce the prevalence of substance use disorder (SUD) and OUD among rural
youth. The SMART (specific, measurable, achievable, realistic, and timely) objectives for the
project are:
1. Youth (12 years to 24 years) in Northern California will be more knowledgeable
about drugs after having access to the GWConnect app for up to 80 days.
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2. Youth will be more knowledgeable of drug treatment resources in Northern California
and how to access them after having access to the app for up to 80 days.
3. Youth will be more likely to use the app to access information on drugs and treatment
resources in Northern California after having access to the app for up to 80 days.
4. Youth will report a high level of satisfaction with the app after having access to it for
up to 80 days.
5. Youth will report that the app is effective in providing information on drugs and local
resources after having access to it for up to 80 days.
Available Knowledge
PICOT Question
The PICOT question is, among youth in a rural Northern California community (P), are
eHealth interventions (I), compared to standard interventions (C), effective in increasing
knowledge related to substance use/misuse and treatment options (O) within 80 days (T)? The
summary of evidence is organized in an evaluation table in Appendix A.
Search Process
A comprehensive search of the available literature was performed using the databases
PubMed, CINAHL, Scopus, PsychINFO, and Joanna Briggs. Search terms included opioid use
disorder/OUD, prevention, treatment, youth, adolescents, mobile application, mobile app, app,
eHealth resource, and eHealth technology. There are opioid abuse and dependence treatment
guidelines in Dynamed for adults, but there are no specific guidelines for MAT among adults or
youth. There were no systematic reviews on MAT for adults or youth in Cochrane. Journal
articles were carefully selected for this manuscript based on the following search criteria: articles
published within the past 6 years and articles in the English language.
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Evidence Appraisal Tool
The Johns Hopkins Nursing Evidenced-Based Practice Appraisal Tool was utilized to
analyze the research (Dang & Dearholt, 2017). The research articles selected for this DNP
project were appraised utilizing the Johns Hopkins Nursing Evidence-Based Practice Evidence
Appraisal Tool (see Appendix A). This rating scale examines the strength of the evidence (e.g.,
Level I-V) and the quality of the evidence (e.g., high, good, or low).
Literature Review
eHealth Resource/Technology
The use of eHealth technology is one proposed intervention to prevent OUD among
youth and connect them with treatment resources and services (Nuamah et al., 2020). The terms
mobile application, mobile app, app, eHealth resource, and eHealth technology all refer to a
computer program or software that runs on mobile devices, including phones, tablets, and
watches. This review will use the aforementioned terms interchangeably.
There has been an increase in eHealth technologies related to drugs; however, the
majority have been developed for use by medical providers as a reference tool for treatment
guidelines and recommendations (Nuamah et al., 2020). Mobile technologies have been
developed for and successfully used in the management of other chronic diseases, including
sickle cell disease, hypertension, diabetes mellitus, and chronic obstructive pulmonary disease, to
name a few (Nuamah et al., 2020). Designing and developing eHealth technologies specifically
for the management of OUD could eliminate a barrier to MAT treatment by allowing the patient
the ability to communicate with a medical provider, track his or her symptoms, and access
evidence-based information and reliable resources related to OUD. This technology could be
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particularly useful among youth due to their familiarity with and affinity towards using
technology in their everyday lives.
Cordova et al. (2018) assessed the usability and acceptability of a mobile health
(mHealth) app among adolescents and its effect on health risk behaviors, specifically drug use,
condomless sex, and STI/HIV testing. The study took a multiple-methods approach and
purposive sampling of 30 adolescents (13 years to 22 years), predominantly African American
and female, in Southeast Michigan. The mHealth preventive intervention was designed in
collaboration with a youth leadership council. Quantitative and qualitative usage data of the
mHealth resource were collected from July to September 2015. The adolescents were asked to
fill out a demographic questionnaire and health risk behavior assessment questionnaire, test the
mHealth resource on iPads, complete modules to assess usability, and participate in either a focus
group or individual interview to discuss the overall experience. Pre-assessment data revealed that
36% of adolescents self-reported illicit drug use within the past 90 days, and 71% of adolescents
self-reported engaging in sexual activity within the past 90 days.
The participants were asked the same open-ended questions about what they thought
about the mHealth app, which aspects they liked or found useful, and what they would change, in
both the post-assessment focus group and the individual interviews. The focus group and
interviews were recorded, transcribed, and analyzed. Content analysis was utilized to organize
the data into categories and themes for analysis. The quantitative data was collected via
demographics questionnaire and health risk behavior questionnaire (0=no, 1=yes). Participants
filled out a 13-item Session Evaluation Form (SEF) with Likert-type responses ranged from 1 for
strongly agree to 5 for strongly disagree, and an 8-item Client Satisfaction Questionnaire (CSQ)
with Likert-type responses ranged from 1 for poor to 5 for excellent. Descriptive statistics
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analysis was used to analyze the demographic and health risk behavior data, and means and
standard deviations were calculated to analyze the SEF and CSQ.
Post-assessment data revealed adolescents reported high levels of usability and
acceptability of the mHealth intervention. Adolescents found that the online risk assessment was
a great way to initiate a conversation with their medical provider about sensitive subjects related
to health risk behaviors. The mHealth resource provided access to information on drugs that
adolescents found to be helpful, increased their knowledge, and gave them tools to use in order
to make informed decisions. Overall, adolescents found the mHealth resource to be helpful in
engaging them in preventing health risk behaviors, specifically related to drug use and sexual
practices. This article is rated Level III and good quality according to the Johns Hopkins Nursing
Evidence-Based Practice Evidence Appraisal Tool (Dang & Dearholt, 2017).
Cordova et al. (2019) assessed feasibility and accessibility of Storytelling 4
Empowerment (S4E), a mobile app aiming to prevent substance use and STI/HIV. This multimethod study utilized community-based participatory research principles (CBPR) and design
thinking to design an app that would engage both medical clinicians and youth. The S4E was
designed, based upon community member input from youth, ages 13 to 22, and clinicians, as
well as innovative approaches taken by the research team, to include a risk assessment tool,
motivational interviewing language to facilitate risk behavior discussions, and referral resources.
The use of S4E was evaluated among medical clinicians and youth, focusing on
improving the communication between them, as well as reducing health risk behaviors among
youth. Both youth and clinicians completed a demographic data survey at baseline. Youth also
completed a baseline health risk behavior questionnaire that focused on drug use and sexual
activity. Youth were asked direct questions about STI and HIV testing prior to and after
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interfacing with S4E. Youth and clinicians were asked questions with Likert-type response
regarding their experience with S4E related to communication between youth and clinician.
Clinicians also completed a post-intervention satisfaction and acceptability survey.
Descriptive statistical analysis was utilized to describe the participants. The preintervention STI and HIV testing data was compared to the data collected post-intervention.
Means were calculated in order to analyze the clinician satisfaction and acceptability survey.
Qualitative post-intervention data was collected during youth and clinician interviews through a
series of open-ended questions assessing overall experience and satisfaction. The interviews are
recorded and transcribed. Content analysis categorized the data into themes.
The data suggested that S4E facilitated prevention approaches to reduce health risk
behaviors, increased STI/HIV knowledge and testing, as well as communication between youth
and clinicians. High levels of feasibility and acceptability were reported by both the clinicians
and the youth. This article is rated Level III and good quality according to the Johns Hopkins
Nursing Evidence-Based Practice Evidence Appraisal Tool (Dang & Dearholt, 2017).
Cordova et al. (2020) stated that mHealth technology can be used to prevent and reduce
health risk behaviors (e.g., substance use and unsafe sexual practices) among adolescents. S4E
was evaluated for its effect on health behavior change among youth. S4E consists of three
interactive online modules on alcohol and drug use and STI/HIV. Fifty youth, ages 13 to 21,
were randomized to either the S4E arm or the standard care arm, with a pre-assessment, postassessment, and a 30-day post-assessment.
Youth and clinicians completed a baseline demographics survey, and then a questionnaire
with Likert-type responses following their interaction to assess their communication, language,
and actions taken regarding health risk behavior services. Youth refusal skills regarding
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substance use were assessed through two questions with responses on a scale of 1 for very hard
to 4 for not very hard. Sexual risk behavior refusal skills were assessed through one question
with responses on a scale of 1 for strongly disagree to 5 for strongly agree. Youth substance use
and sexual risk prevention knowledge was assessed through four questions with an agreement
scale. Finally, youth behaviors regarding substance use, sexual risk, and HIV/STI testing were
assessed through yes and no answers, where 1 was used for yes and 0 was used for no.
Descriptive statistical analysis was utilized to analyze baseline data and any differences
between the S4E arm and the standard care arm. Chi-square tests and 2-tailed t tests analyzed
differences between the groups from the start of the study to the 30-day follow-up evaluation.
Post-intervention changes regarding reported substance use, sexual risk behaviors, and STI/HIV
testing were compared between the groups.
Randomization was successful in this study as there were no differences between groups
at baseline. There no differences between the groups in either attrition (P=.92) or number of days
to follow-up (P=.68). The S4E youth reported more risk communication with the clinicians
(P=.58). The S4E clinicians also reported more risk communication with the youth (P=.45). The
S4E youth reported a greater change in refusal skills for alcohol (P=0.67) and drugs (P=0.68).
The S4E youth also reported greater change in prevention knowledge regarding sexual risk
(P=.60) and STI/HIV (P=.34). There was not a significant change in reported substance use
from baseline. The S4E group reported increased STI/HIV testing (P=.57).
Youth in the S4E arm demonstrated a reduction in health risk behaviors over the past 30
days, including substance use, as well as increased knowledge of prevention strategies. mHealth
technology can be utilized to reduce substance use and other health risk behaviors among youth.
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This article is rated Level I and good quality according to the Johns Hopkins Nursing EvidenceBased Practice Evidence Appraisal Tool (Dang & Dearholt, 2017).
Scheier et al. (2019) gathered stakeholder input on the design of an online, family-based
drug prevention program called Strengthening Families Program (SFP). The in-person format
has proven to be effective in preventing youth drug and alcohol use, but that delivery method
requires a lot of resources. This mixed-methods study was a Phase I National Institute of Health
funded Small Business Innovative Research Grant. The study engaged subject-matter experts and
stakeholders in the design of the online SFP delivery. They conducted interviews with prevention
and online learning experts and family services personnel. They also surveyed and conducted 10
focus groups with 85 adults.
A subject matter expert panel was convened, including five prevention scientists and five
e-learning experts, for a teleconference interview. The subject matter experts answered questions
regarding the feasibility of SFP online, its features, and how to implement it. Parents completed
consumer preference surveys containing questions with either yes or no responses or Likert-type
responses. The focus groups were recorded and transcribed for thematic analysis.
The principal findings of the thematic analysis revealed that the online program should
include the drug prevention content in an interactive and engaging manner. There was an
emphasis placed on brief skills-oriented sessions, graphics over text, animation, real-life role
play scenarios, connection with agency personnel who can monitor progress, and printable
materials to work on at home. This study informed the design and development of curriculum for
an online, family-based drug prevention program based upon what the family wants to learn, in
the preferred delivery format, and with features that facilitate engagement and retention. This
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article is rated Level III and good quality according to the Johns Hopkins Nursing EvidenceBased Practice Evidence Appraisal Tool (Dang & Dearholt, 2017).
Schuman-Olivier et al. (2018) assessed the feasibility, usability, and acceptability of
MySafeRx, a mobile resource developed to promote buprenorphine/naloxone treatment
adherence. They conducted a 28-day, single-arm, observational study of the use of MySafeRx
resource among early adults (18 years to 39 years) receiving buprenorphine/naloxone (B/N) for
treatment of OUD. The MySafeRx technology incorporates motivational mentorship, ability to
message your medical provider, and medication monitoring. The MySafeRx technology includes
a secure electronic medication organizer that the app can unlock, text messaging with the
treatment program, daily videoconference with a trained mobile recovery coach utilizing
motivational interventions, and supervised medication self-administration via videoconference.
The study began with an in-person training on the use of MySafeRx technology. The
study participants attended a daily videoconference with a trained mobile recovery coach,
completed weekly surveys regarding feasibility, usability, and acceptability, as well as weekly
urine toxicology screenings during the 28-day study and for an additional 4-weeks postintervention.
Study participants completed a baseline survey about demographics, substance use
history, and technology use. Supervised medication self-administration through
videoconferencing and medication adherence surveys assessed app feasibility. The initial inperson training and a post-intervention survey assessed app usability. A weekly satisfaction
survey, a post-intervention satisfaction survey, and urine toxicology screening assessed app
acceptability.
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Descriptive data analysis was utilized. In terms of feasibility, two-thirds of participants
completed supervised medication self-administration 5 or more days per week and 83% selfreported medication adherence. The in-person training resulted in high levels of user competency
and the post-intervention survey demonstrated an average system usability score of 78.8. The
satisfaction surveys revealed overall satisfaction with the pill dispenser, videoconference, and
text messaging, and 75% of the participants expressed interest in continuing to use MySafeRx.
The urine toxicology results demonstrated a 41.7% average level of illicit opioid abstinence
during the first week of the study which increased to 63.6% during weeks three and four.
Illicit opioid abstinence increased by 53% during the 28-day trial period. Participants
reported good levels of usability and acceptability of the MySafeRx technology. The MySafeRx,
or other similar mobile technology, can be used to increase adherence to OUD treatment. This
article is rated Level III and good quality according to the Johns Hopkins Nursing EvidenceBased Practice Evidence Appraisal Tool (Dang & Dearholt, 2017).
Rationale
Conceptual Framework
The conceptual framework that guided this project was the social ecological model
(SEM). Urie Bronfenbrenner introduced the SEM as a conceptual framework in the 1970s, and it
was later adapted into a theory in the 1980s (Kilanowski, 2017). Using the SEM helps describe
the interconnectedness of individual, relationship, community, and societal factors, and how they
influence health behaviors (CDC, 2021b). The individual is at the center of this model; the next
layer includes relationships which are the microsystem that has the most impact on the individual
(Kilanowski, 2017). Then, there is the community which is the mesosystem that includes work,
school, church, and neighborhood (Kilanowski, 2017). Finally, there are societal factors,
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including social networks, which account for the exosystem that indirectly influences the
individual (Kilanowski, 2017). A successful intervention will address all SEM levels in order to
truly impact health behavior and create change (CDC, 2021b).
The opioid crisis has persisted for several decades within the United States, and most
efforts to thwart its progression have been directed towards adults with OUD. On average, most
people who use or misuse drugs had their first encounter with drugs at 12- to 13-years old;
however, few interventions target this age group (Natural High, 2020). My team wanted to tailor
this eHealth resource to youth because significant efforts have not been made to update and
deliver drug prevention and treatment initiatives that are relevant to today’s youth population in
order to address this issue at time of onset.
The Granite Wellness Center Youth Resiliency Program (GWCYRP), which encompasses
my project, is trying to create change by developing and delivering preventive and treatment
strategies specific to youth with OUD within the community that is affected by this problem. On
the individual level, my project sought to become acquainted with our primary stakeholders via a
focus group and an online survey to gain a deeper understanding of their beliefs and attitudes
towards substance use, misuse, and treatment. That information has driven the design and
development of the eHealth technology from the beginning. On the relationship level, we
discussed how relationships influence behavior, and we learned that our primary stakeholders
were seeking peer connection and support when looking for information on substance use,
misuse, and treatment. As a result, we enabled a feature in the mobile eHealth resource called
GWConnect (Granite Wellness Connect) to allow for peer-to-peer connection and
communication. On the community level, we collaborated with experts in harm reduction in
order to best communicate with our stakeholders. We received contributions from local artists to
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improve the aesthetic of the app, and we communicated with other local drug and alcohol
facilities to build a database of available services in the local area. On the societal level, we
wanted to create an eHealth resource that was customized to our primary stakeholders in Nevada
and Placer Counties. We also wanted GWConnect to be available to anyone looking for such a
resource, whether a young person in need of information on drugs or a medical provider in need
of a tool to engage a young person in drug treatment. Therefore, GWConnect will be readily
accessible to anyone who has access to the Google and Apple stores. Essentially, anyone can use
and may benefit from the app, and other communities can utilize it to engage with their youth
population.
Harm reduction principles also guided this project. The concept of harm reduction is to
reduce the deleterious effects of health behaviors without completely eliminating the health
behavior itself (Hawk et al., 2017). Hawk et al. (2017) defined six principles of harm reduction:
1. Humanism refers to the fact that every individual deserves respect and dignity, and
there is an understanding that harmful health behaviors also benefit the individual in
some way, so it is of value to assess both the harm(s) and the benefit(s) in order to
gain a better understanding as to why individuals make certain decisions.
2. Pragmatism refers to the fact that perfection is not attainable, even when it comes to
health behaviors, and social and environmental factors influence behavior, and
therefore, should be taken into account to better understand the underpinnings of the
behavior.
3. Individualism refers to the fact that every person has his/her own needs and strengths,
and it is essential to tailor intervention options in order to find the best fit for the
individual at that particular time in his/her life.
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4. Autonomy refers to the fact individuals make health decisions for themselves, and
medical providers should provide information that empowers the individual to make
an informed decision.
5. Incrementalism refers to the fact that any positive change, no matter how small, can
improve health, with the understanding that one can plateau or even regress
throughout this process.
6. Accountability without termination refers to the fact that individuals are accountable
for their actions, and medical providers can help them understand their actions and
the consequences without terminating the relationship for not progressing in a linear
manner.
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Section III. Methods
Context
There is an unmet need to provide youth with access to culturally-informed harm
reduction tools in order to reduce the incidence of OUD. Providing youth with unbiased drug
information, Narcan information, news alerts, ask-a-provider feature, and referral resources can
increase knowledge and informed decision-making and reduce barriers to treatment access. An
eHealth resource is the ideal means to deliver this information to youth, given their avid use of,
familiarity with, and ready access to this technology (see Appendix B. Gap Analysis).
The Organization: Granite Wellness Centers
This project was completed at Granite Wellness Centers (GWC). Formerly known as
Community Recovery Resources, GWC is a nonprofit 501(c)(3) corporation that has been
providing drug and alcohol treatment in Northern California since 1974 (GWC, 2021). The GWC
has six locations throughout Nevada and Placer Counties and employs 165 staff members (GWC,
2021). The GWC has an annual operating budget of approximately $10 million. Funding sources
include local, state, and federal grants, as well as donations and contributions (GWC, 2021).
The GWC’s (2021) mission statement is to promote wellness and quality of life. They
provide drug and alcohol treatment in inpatient and outpatient settings, MAT, detoxification,
driving under the influence classes, transitional housing, treatment for adolescents, services for
parents and families, life skills and wellness, and drug testing services (GWC, 2021). The
majority of these services are for adults, 18 years and older, unless specifically identified as
adolescent services. The GWC is actively working towards expanding services for adolescents.
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Granite Wellness Centers Youth Resiliency Project
The California Youth Opioid Response (YOR California) awarded GWC with a $500,000
grant to fund GWCYRP. The purpose of the GWCYRP is to develop and deliver a system of care
that addresses OUDs among young people. The values for the GWCYRP are “respect, cultural
humility, innovation, partnership, and integrity” (California Institute for Behavioral Health
Solutions, 2015, p. 1). The target population for this project is young people ages 12 years to 24
years in rural Nevada and Placer Counties. This DNP project was one of the many projects under
the GWCYRP umbrella.
The California Youth Opioid Response (YOR) team developed an implementation plan
consisting of six goals to direct the grant recipients’ use of the funds. My project is specifically
involved in Goal 5, which states, “Prevent opioid misuse, abuse and overdose deaths, and reduce
use of opioids among youth ages 12-24 with the development of culturally-informed, youth
sensitive clinical services available on a drop-in, confidential basis” (California Institute for
Behavioral Health Solutions, 2015, p. 2). The objective for Goal 5 is as follows,
Utilizing a Positive Youth Development Framework, develop and implement culturally
and trauma informed youth sensitive clinical services focused on behavioral health issues.
GWCYRP adolescent health clinical services will address the critical components of
youth sensitive services, including: accessibility, confidentiality, availability of providers
specifically trained in adolescent health care, use of an innovative, nontraditional health
care setting in a safe environment, and the implementation of eHealth technologies
(California Institute for Behavioral Health Solutions, 2015, p. 2).
There are many community-based organizations that are stakeholders in GWCYRP and
support the implementation plan in various capacities, to include, the Coalition for Auburn
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Youth, the Coalition for Nevada County Youth, Chapa De Indian Health, Sierra Care Pediatrics,
Nevada County Health and Human Services, Placer County Health and Human Services, Placer
Nevada Rx Safety Coalition, Idea Consulting, Youth from Nevada Union High School, Nevada
County Superintendent of Schools Tobacco Use Prevention Education, Placer County Office of
Education, and multiple regional school districts (California Institute for Behavioral Health
Solutions, 2015).
Interventions
The DNP student was a member of the GWConnect team, which consisted of the grant
principal investigator, software engineer, youth coordinator, app designer, lead app developer,
and a public health expert. The team conducted in-person focus group and online survey (due to
COVID-19 restrictions) to assess the needs of our primary stakeholders. Invitations to attend the
focus group were sent to high schools in Nevada and Placer Counties, and the online survey was
advertised via social media. The focus group included 15 participants and the online survey had
28 respondents. The focus group and online survey data informed the design and development of
the eHealth drug resource.
The DNP student contributed to the design and development of the eHealth drug resource
by building an evidence-based drug dataset and recording a guided body scan for inclusion in the
app. The DNP student also conducted a pilot project, in which youth in Nevada and Placer
Counties were given access to the app for 80 days and asked to complete pre- and post-surveys
assessing knowledge of drugs and local treatment resources. The pilot project had 29
participants. The pre-survey results reveal limited knowledge of evidence-based information on
drugs and available treatment resources, resulting in an underserved adolescent population with
OUD or at risk of developing an OUD.
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Gap Analysis
A gap analysis was conducted for this DNP project to assess the current state of this issue,
the desired state, and the action needed (see Appendix B). An individual risk factor for youth
substance use has been cited as a deficiency of knowledge regarding drugs and risk of use
(Griffin & Botvin, 2010). The current state is limited knowledge of evidence-based information
on drugs and available treatment resources, resulting in an underserved adolescent population
with an OUD or at risk of developing an OUD. The desired state is access to evidence-based
information on drugs and available treatment resources within a rural Northern California
community in order to improve knowledge about drugs and use/misuse, as well as awareness of
and how to access the available treatment resources within the local area. The action needed is to
design and develop an eHealth drug resource specifically for the adolescent population within
this rural Northern California community, publish it to the Google and Apple store for free
download, and incorporate it into treatment protocols for youth with OUD at GWC.
GANTT Chart
A GANTT chart was utilized to outline the DNP project timeline from June 2020 to May
2021 (see Appendix C). A literature review was conducted regarding the use of eHealth
resources to prevent and treat OUD among youth. The DNP committee, consisting of the
committee chair and second reader, was assembled. Meetings between the DNP student,
committee chair, and the GWConnect team were conducted. A focus group and an online survey
of the primary stakeholders, youth 12 years to 24 years in Nevada and Placer Counties, were
conducted. The data from the focus group and online survey informed the design and
development of the app, which occurred from September to December 2020. The DNP student
organized and conducted a GWConnect pilot program from January to April 2021. Youth in
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Nevada and Placer Counties were given access to the app for 80 days and asked to fill out online
surveys prior to and following testing of the app. The survey data were collected and analyzed
from February to May 2021. The DNP project write-up began in January 2021 and was
completed by May 2021. The paper was disseminated to the committee chair and the second
reader, and final edits were made. The DNP project was presented to University of San Francisco
faculty and students in May 2021.
Work Breakdown Structure
Project details are outlined in a work breakdown structure (WBS; see Appendix D). The
development of an eHealth harm reduction resource occurred in five phases: design, plan,
intervention, results and evaluation.
During the design phase, the scope of the project was developed. A gap analysis was
completed based upon a thorough literature review and a needs assessment specific to GWC in
Grass Valley. Based on the gap analysis, project objectives were developed. Key stakeholders
were identified. The DNP student met with the key stakeholders to better understand the vision,
mission, and goals for GWC and for this project. A project charter was developed and submitted
to the DNP chair for review.
During the plan phase, the GWConnect team was identified, with a discussion of roles. A
project plan and the WBS were developed. The focus group questionnaire and surveys were
developed and finalized.
During the intervention phase, the focus group and initial online survey were conducted
to gather data from the primary stakeholders that would inform the design and development of
the app. The data were analyzed and the GWConnect app was designed and developed. The DNP
student researched and built an evidence-based drug data set and collaborated with personnel
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familiar with harm reduction principles in order to tailor the data set to the primary stakeholders.
The DNP student also recorded a guided body scan for inclusion in the GWConnect app. The
DNP student conducted an app pilot program of the app and administered pre- and post-testing
surveys.
During the results phase, the survey findings were analyzed. The findings were
summarized and recommendations written. The evaluation phase consisted of reviewing
feedback from surveys and verifying that recommendations align, writing the final report,
submitting the DNP paper, and presenting the project to the University of San Francisco staff.
Communication Matrix
Communication between all members of the GWConnect team and all stakeholders in the
DNP project was critical throughout every stage of this project. The DNP student maintained
direct communication throughout the entirety of this project with the committee chair via Zoom
and email. The GWConnect team communicated on a regular basis via email, Zoom, team
Dashboard account, and team Slack channel. A GWConnect webpage was created as a resource
for the pilot program participants, which contained background information on the app and
contact information for any questions. A communication matrix was created for the DNP project
(see Appendix E).
Strengths, Weaknesses, Opportunities, and Threats
An analysis of the strengths, weakness, opportunities, and threats (SWOT) was conducted
(see Appendix F).
Strengths
The vast majority of youth are familiar with and have ready access to mobile
technologies. Youth usually have some sort of mobile technology with them most of the time,
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making a mobile app an ideal intervention to use in this population. A main strength of this
project is that mobile technologies have been successfully used to prevent and manage other
chronic diseases. During the COVID-19 pandemic, people have become more reliant on mobile
technologies to connect virtually due to limitations on in-person interactions. Another strength of
this project is that increased knowledge can facilitate informed decision-making for youth that
can prevent OUD. The app design and development were based on primary stakeholder data
obtained via focus group and online survey; the app was designed and developed specifically for
youth 12 years to 24 years in Nevada and Placer Counties. Finally, the app was funded through
the YOR California grant, and the project had buy-in from the GWC administration.
Weaknesses
The fact that the app was designed and developed for youth 12 to 24 years in Nevada and
Placer Counties is both a strength and a weakness, because youth in other counties may not find
it applicable to them. A main weakness of this project is the ability to connect with youth and
have them download the app, and then to keep them engaged so they will continue to use it. The
app requires a medical provider to answer any questions asked, requiring frequent monitoring of
the app in order to provide a timely response. The app also requires updates regarding news
related to drugs, substance use, and warnings in the local area. Another weakness of this project
is that the app will require continuous updates to remain compatible with Android and iOS
operating systems. Finally, there are costs associated with maintaining and updating the app over
time.
Opportunities
Initial research revealed that there is no comparable product currently available on the
market. Primary stakeholders reported what they were looking for in an eHealth resource through
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the focus group and online survey, which gave the team the opportunity to design and develop
the app specifically for the primary stakeholders. This project creates an opportunity to connect
with youth in a medium they prefer, are familiar with, and have ready access to. This project also
offers the ability to remain connected with youth, even during the COVID-19 pandemic when inperson interactions are limited. Youth will have the opportunity to access evidenced-based
information on drugs and treatment resources and to ask a medical provider questions in a
secure, confidential, and non-confrontational manner. This project will dispel common myths
about drugs and drug use. This project will prevent OUD among youth in Northern California.
Threats
One threat is app buy-in by youth. Youth may have a fear that their parents/guardians or
the app administrator(s) are monitoring their activity, and simply accessing drug information
could be perceived as thinking about or actually using drugs. Another threat is parents/guardians
having a misperception that allowing youth to access information will make them more apt to
use drugs. There is also concern that the YOR California grant funding may not be renewed.
Overall, the strengths outweigh the weaknesses of this program. Based on the SWOT analysis,
the program is feasible completed.
Budget
The proforma for this project is forecasted for 3 years and accounts for changing
expenses over the life of the program, with a 3% increase in Year 2 and Year 3 over the previous
year (see Appendix G). The YOR California, funded by the California Department of Health
Care Services (DHCS), awarded 22 grants totaling $11 million in order to address OUD among
youth ages 12 years to 24 years in rural Northern California communities (California Institute of
Behavioral Health, 2015). In 2020, GWC received a $500,000 grant and allocated the funds to
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the GWCYRP, $25,000 of which funded the design and development of the eHealth resource.
The DHCS renewed the funds in 2021, securing this grant as a reliable funding source.
GWC (2021) is a nonprofit 501(c)(3) corporation; therefore, there are no deductions from
revenue. The 2016 and 2017 tax returns (Form 990) filed by GWC (formerly known as
Community Recovery Resources or CoRR) were reviewed, and it was verified that there were no
deductions from revenue.
The youth focus group was conducted at GWC and there were no associated fees. The
youth online survey was generated and distributed online at no charge. The initial $25,000 grant
funds covered the cost of hiring an app designer and an app developer and the fees associated
with registering the app with Google (one-time $25 fee) and Apple ($99 annual fee) app stores.
The app will be available as a free download for users.
The pre- and post-pilot surveys were generated through Qualtrics for free and distributed
via email. All participants who completed the pilot program, including and the pre- and postsurveys, were given $5 Amazon ecards, totaling $60. The DNP student used personal funds to
finance the Amazon gift card incentive. Additional supplies included printouts/handouts and
pens; the budget for supplies was $100 in the first year ($60 for Amazon ecards and $40 for
printouts/handouts and pens).
A part-time nurse practitioner and part-time app developer will regularly interact with the
app, chat with users, answer questions posted, upload current events and warnings related to
drugs, and schedule software updates, as needed, to ensure ease of use and accessibility. A
portion of the 2021 grant funds are earmarked to cover the costs associated with maintaining and
updating the app.
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Return on Investment
According to Salary.com (2021a, 2021b), the average nurse practitioner salary in Nevada
County, California is $113,473 (range $105,481 to $123,487), and the average salary for an app
developer in California is $73,973 (range $66,158 to $84,378). The total wages are $81,737 in
Year 1, $95,426 in Year 2, and $98,288 in Year 3. The employees are independent contractors
who do not receive benefits. The total expenses are $81,837 in Year 1, $95,529 in Year 2, and
$98,394 in Year 3. The revenue less expenses is in the green for all 3 years: $418,163 in Year 1,
$419,471 in Year 2, and $432,056 in Year 3.
A return on investment (ROI) can be calculated for this project. Society will get a return
on their investment in the form of significant cost savings and expense avoidance through
GWConnect (see Appendix H). The long-term goal of GWConnect is that youth in Northern
California will access it and report increased knowledge of drugs, which will result in decreased
incidence of SUD among this population and, as a corollary, prevention of nonfatal and fatal
overdoses.
The societal cost of opioid addiction per person can be calculated by totaling the
associated healthcare, law enforcement, and legal costs (Florence et al., 2016). The total societal
cost of nonfatal OUD was $57 billion. This number can be divided by the number of people with
an OUD in 2013 (1.9 million), resulting in a societal cost of $30,000 per person per year for
nonfatal OUDs. The total cost of fatal opioid overdoses was $21.5 billion, divided by 16,235
deaths due to fatal opioid overdose in 2013, equates to a societal cost of $1.3 million per fatal
opioid overdose. The societal cost savings of one avoided fatal overdose is $1.3 million. There
are an average of 136 fatal opioid overdoses per day, resulting in a potential cost savings of
$176.8 million ($1.3 million multiplied by 136; CDC, 2021).
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To calculate the ROI, the cost of designing, developing and distributing GWConnect
($81,837) is subtracted from the cost savings of just one avoided fatal overdose ($1.3 million)
and divided by the cost ($81,837) to equal 14.89. The ROI for this project, in the form of
societal cost savings and expense avoidance, is 1,489%! That is a significant ROI, making this
project fiscally sound and worthwhile.
Study of the Intervention
This DNP project aimed to design and develop an eHealth technology, GWConnect, for
youth to increase awareness and knowledge of drugs and their effects, risks associated with
substance use, and local resources available for SUD evaluation and treatment, within the
context of harm reduction principles. An in-person focus group and an online survey (due to
COVID-19 restrictions) were conducted to assess the needs of our primary stakeholders. The
data collected informed the design of the GWConnect.
The GWConnect pilot program was conducted to evaluate its effectiveness in achieving
the aforementioned short-term goals among the primary stakeholders. Pre- and post-pilot
program surveys were administered to all study participants. Survey data were collected and
analyzed using Qualtrics. The data findings were presented to the GWConnect team and used to
update GWConnect prior to launching in Google and Apple stores, as well as to inform future
app updates.
The long-term goal of GWConnect is that youth in Northern California will access it
and report increased knowledge of drugs, which will result in decreased incidence of SUD
among this population. Another long-term goal of this project is that youth will access the
mobile app and report increased knowledge of local drug treatment resources, resulting in early
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diagnosis of SUD and timely entry into treatment in order to improve long-term health
outcomes. A longitudinal study is needed to assess the long-term outcome measures.
Outcome Measures
The outcome measures for this DNP project were to work with the GWConnect team to
conduct primary stakeholder in-person focus group and online survey, contribute to the design
and development of GWConnect, conduct a pilot program including pre- and post-assessment
surveys, analyze pilot program data, and create a final presentation with recommendations for
future updates to GWConnect.
The GWConnect team conducted a focus group of our primary stakeholders during the
initial planning phase in order to gain a better understanding of what youth were looking for in
an eHealth drug resource. An advertisement seeking focus group volunteers was distributed to
the local high schools in Nevada and Placer Counties. Inclusion criteria was anyone aged 12
years to 24 years old residing in Nevada or Placer Counties. There were 15 respondents (eight
females and seven males) who attended the focus group. Youth were asked what features should
be included in this app, if there were any other similar resources on the market they find helpful,
the language that should be used, how it should be marketed, and any other advice they would
like to offer.
The survey was advertised online via social media. Inclusion criteria was anyone 12 years
to 24 years old residing in the United States; there were 28 respondents. The survey attempted to
gather basic information for a general persona of our primary stakeholders, information that
should be included in the drug info guide, how an interactive map of local resources should look,
how information should be presented (e.g., text, illustration, video, audio), the ideal aesthetic for
the app, and any other input the participant would like to contribute.
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The survey collected demographic data, including age and gender. The survey attempted
to get to know the primary stakeholders better through the following questions: What apps do
you use most? Who are the most creative or interesting people you follow on Instagram (name at
least three)? What’s a brand or online store you think is particularly cool? Where do you hear
about the news? What’s your favorite way to learn new things? The survey assessed commonly
used drugs among youth in a non-confrontational manner by asking the following question:
What do you think are the most frequently used drugs among your friends and classmates? The
survey assessed how informed youth were about drugs, their use, and their effects according to a
scale of 0 to 10, in which 0 was not informed at all and 10 was very informed. The survey
assessed if youth have ever looked for or asked someone for information about drugs and their
effects, and if so, where did they look and/or who did they ask? The survey assessed if there is
information that they would like to ask about drugs, but they are unsure how to ask or where to
find the answer. The survey asked the respondents to rank the following drug information in
order of importance: scientific names, street names, photos, precautions and safety for use,
effects, duration of effects, risks, interactions with other substances, likelihood of addiction, how
to test a substance for safety, antidotes/reversal agents, personal experiences, and an Other freetext answer. The survey assessed for any fears related to drugs. Finally, the survey asked if they
have come across and/or used any drug or alcohol-related resources that they found particularly
helpful.
The DNP student conducted a review of evidence-based resources to build a drug
information database. The drugs included in the database were cocaine, heroin, inhalants,
lysergic acid diethylamide (LSD), marijuana, 3,4-methylenedioxy methamphetamine (MDMA),
methamphetamine, phencyclidine (PCP), synthetic cannabinoids, synthetic cathinones, tobacco,
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alcohol, prescription central nervous system depressants, prescription opioids, prescription
stimulants, prescription anabolic steroids, over-the-counter (OTC) dextromethorphan, and OTC
loperamide. The database included information on drugs, including commercial names, street
names, a brief description of the drug, common forms, common ways the drug is taken, the Drug
Enforcement Administration schedule/classification, short- and long-term effects, other healthrelated issues, withdrawal symptoms, and treatment options, including medications and
behavioral therapies. One of the recurrent themes of the focus group and initial online survey
was the importance of incorporating mindfulness components, such as meditations and body
scans, into this app. Therefore, the DNP student also researched and recorded a 6-minute guided
body scan meditation for inclusion in the app.
The GWConnect app pilot program was conducted from March to May 2021. Inclusion
criteria was anyone 12 years to 24 years residing in Nevada and Placer Counties. The completion
of a pre- and post-survey was required. The survey collected demographic data, including state
and county of residence, age, gender, possession of mobile device, the operating system of their
device, and email address. An email invitation was sent to each participant containing a unique
code to download GWConnect. The participants were given access to the app for up to 80 days
and were instructed to peruse all the features and take notes in real-time in order to provide
feedback in the post-pilot survey.
The pre-pilot survey (Appendix I) assessed baseline knowledge of drugs and local drug
treatment resources through the following two questions: How knowledgeable do you feel about
drugs? If you or someone you know needed help for drug use/misuse, how knowledgeable are
you regarding where resources are in your local area and how to access them? Likert-type
responses ranged from 1 for not knowledgeable at all to 5 for extremely knowledgeable. The
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survey assessed baseline likelihood that youth would use the app to access information on drugs
and local treatment resources through the following questions: How likely are you to use a
mobile app to access information on drugs? How likely are you to use a mobile app to access
information on treatment resources in your local area? Likert-type responses ranged from 1 for
extremely unlikely to 5 for extremely likely. The final question allowed multiples answers and
asked: What features are important to include in a mobile app containing information on drugs
and related resources? The answer choices included drug facts and figures, treatment resources,
mindfulness activities, education on Narcan, warnings related to drug use in your community
(e.g., uptick in fentanyl overdoses), ability to chat with and ask a medical provider questions,
Q&A Forum, and a free-text option.
The post-pilot survey (see Appendix J) assessed for any changes in knowledge of drugs
and local drug treatment resources, after having access to GWConnect for up to 80 days, through
the following two questions: After beta testing the Granite Connects app, how knowledgeable do
you feel about drugs? After beta testing the Granite Connects app, how knowledgeable are you
regarding drug treatment resources are in your local area and how to access them? Likert-type
responses ranged from 1 for not knowledgeable at all to 5 for extremely knowledgeable. The
survey assessed for any changes in likelihood that youth would use the app to access information
on drugs and local treatment resources through the following two questions: After beta testing
the Granite Connects app, how likely are you to use this app in order to access information on
drugs? After beta testing the Granite Connects app, how likely are you to use it in order to access
information on treatment resources in your local area? Likert-type responses ranged from 1 for
extremely unlikely to 5 for extremely likely. The survey assessed usefulness of the features
through the following question: After beta testing the Granite Connects app, which feature(s) did
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you find informative and/or useful? This question allowed for multiple answers, and the choices
included drug facts and figures, treatment resources, mindfulness activities, education on Narcan,
warnings related to drug use in your community (e.g., uptick in fentanyl overdoses), ability to
chat with and ask a medical provider questions, Q&A Forum, and a free-text option. The survey
assessed satisfaction through the following question: How satisfied are you with the Granite
Connects app? Likert-type responses ranged from 1 for extremely unsatisfied to 5 for extremely
satisfied. The survey assessed effectiveness through the following question: How effective is the
Granite Connects app in providing information on drugs and local resources? Likert-type
responses ranged from 1 for not effective at all to 5 for extremely effective. The final question
asked what improvements can be made to the app and allowed for multiple free-text answers.
Analysis
The primary stakeholder focus group took place in-person at GWC Grass Valley location.
The group sat in chairs arranged in a circle. The questions were verbally posed to the group, and
each participant verbally responded with an answer. All of the participant responses were
annotated. The GWConnect team reviewed the transcript and thematically analyzed the data. The
primary stakeholder survey was distributed online. The intent of the survey was to learn more
about the primary stakeholders and what they were looking for in an eHealth resource, so the
data were analyzed both qualitatively and quantitatively. The survey responses were entered into
Excel and arranged in charts and graphs. The demographic data were depicted in pie charts.
Microsoft Word was utilized to create a word cloud that depicted the frequency with which the
respondents used various apps. Thematic analysis was applied to the social media accounts that
they followed and the overall messages that those accounts were sending, as well as to describe
the aesthetic of those accounts.
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Excel calculated the percentage of respondents who used some sort of mindfulness app.
Their go-to news-related resources and the ways in which they prefer to learn were arranged in
bar charts. The respondents ranked substances from most to least commonly used among their
friends and classmates, and those answers were arranged in a bar chart. Drug-related insight data
were depicted in a bar chart. Yes/No responses regarding whether or not youth sought out
information on drugs were depicted in a pie chart. Answers to the follow-up, free-text question
regarding where they looked or who they asked were listed in a chart. The respondents ranked
various information related to drugs as either very important, important or not important, and
that information was depicted in a bar chart. Fears related to drugs were organized in a bar chart.
The free-text answers regarding use of any informative drug-related resources were listed in a
chart.
A Google spreadsheet was utilized to track participation in the pilot program. Qualtrics
was used to create and distribute the pre- and post-pilot surveys and to collect the qualitative
data. Qualtrics organized the pre- and post-pilot survey data into tables and either bar or pie
charts, which were easily exported for visual comparison. The Likert responses were numerically
ranked from not knowledgeable at all (1) to extremely knowledgeable (5), extremely unlikely (1)
to extremely likely (5), extremely unsatisfied (1) to extremely satisfied (5), and not effective at all
(1) to extremely effective (5). The pre- and post-pilot survey responses were analyzed by
Qualtrics, and the mean percent change, standard deviation, and variance were reviewed to
determine the effectiveness of the pilot program in increasing knowledge of drugs and local
treatment resources among the youth who participated. Percentages of satisfaction and app
effectiveness were calculated. The GWConnect team reviewed all free-text answers regarding
current and future revisions to the GWConnect app.
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Ethical Considerations
The University of San Francisco DNP department determined that this project met the
guidelines for an evidence-based practice change project, as outlined in the project checklist, and
was determined to be non-research (see Appendix K). The project received support and
permission from GWC (see Appendix L). One of the tenets of the GWConnect is user
confidentiality because it was important to our primary stakeholders and to the GWConnect team
to create a drug resource that youth can access at any time without fear of being monitored in any
way. As a result, GWConnect does not collect any personal data.
This project relates to the Jesuit value of cura personalis or care of the whole person:
mind, body, and spirit. Preliminary resource and data obtained from the primary stakeholders
revealed a lack of available resources relevant to all of the stakeholders’ needs. The aim of this
project was to design and develop a substance use prevention and treatment resource specifically
for youth, as directed by youth, taking a holistic approach to better meet their mind, body, and
spiritual needs in a format that they prefer (Ctzejanda, 2019).
This DNP project relates to the American Nurses Association (ANA, 2015) Code of
Ethics Provision 1.4 The Right to Self-Determination, which incorporates the ethical principle of
autonomy. The DNP student recognized that youth have a right to be active, informed
participants and to direct their care, in so far as the law allows. As a result, youth were engaged
throughout the entirety of this project. Youth informed the GWConnect team that they
overwhelmingly prefer a harm reduction versus abstinence-only approach; therefore, this project
is based upon harm reduction principles.
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Section IV. Results
Qualitative data were collected through a primary stakeholder focus group and survey
prior to the design and development of the GWConnect mobile app. Surveys were also
administered prior to and after the GWConnect pilot program. The results of the focus group and
surveys are discussed in detail.
Youth Focus Group
An invitation to attend an in-person focus group and provide input on the design of an
eHealth drug resource was distributed to local high schools in Spring 2020, with 15 attendees
(eight girls and seven boys). Inclusion criteria was anyone aged 12 to 24 years old residing in
Nevada or Placer Counties.
When asked about the language that should be used in the eHealth resource, they advised
us to:
•

Avoid sounding like a school assignment.

•

“Don’t sound preachy” by avoiding should/should not statements because they did
not want to be told what is good versus bad.

•

No drug-shaming or overt or covert shaming for using drugs.

•

Include fact-oriented information without any explicit persuasion to not use drugs.

•

Use self-help/mindfulness language.

•

Invite, rather than tell, the user to use the eHealth resource, thereby encouraging
choice/self-determination.

•

Preferential to pictures versus words.

When asked how to market this app, they advised us to advertise it in schools and offer
some sort of monetary incentive to entice people to use it. They referred us to a website,

DEVELOPMENT OF AN EHEALTH HARM REDUCTION RESOURCE

47

DanceSafe.org, that took a similar approach at a music festival; DanceSafe.org representatives
offered $100 to each person who visited their website and signed a pledge to not use drugs
during the music festival.
When asked about other resources to model this eHealth resource after, they informed
us of Erowid, Psychoactive Vaults, Welcome to the DMT-Nexus, and GritX. We visited the
websites and noted that they were easy to navigate, utilized graphics and videos, graphics were
colorful and enhanced the drug education content, and the language was informative and nonjudgmental.
Other advice we received was to put an inspirational quote on the Home screen, as well
as news about drugs, with a link to the full article. They expressed interest in having the
capability to bookmark articles of interest in a “My Articles” section. They advised us to have a
searchable dictionary of drugs that includes information on the chemical makeup, dosage, side
effects, and what the drug does to the body, as well as a lot of pictures of the actual drugs.
Based on this feedback, the search bar was the first feature we built into the eHealth
resource, which allows the user to search for anything on the eHealth resource directly from the
Home screen. The DNP student built the drug data set based upon their feedback and included all
of the aforementioned information, including pictures of the drugs in their various forms from
the FDA picture database. The DNP student also researched and uploaded a “How to use
naloxone” video on the homepage of the app. The GWConnect team is still working on
incorporating a news ticker that crawls across the Home screen, which would highlight current
news related to drugs and allow the user to click and access the full article for more information.
The focus group suggested incorporating mindfulness features, such as breathing/
meditation, goal tracking, journaling, or mood tracking. The breathing/meditation feature can
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include guided meditations, a calming music playlist to choose from, and breathing exercises
with visual animation. The DNP student researched and recorded a 6-minute body scan
meditation for inclusion in the mindfulness section of the app.
The youth advised us that a goal tracker should allow the user to set their own short- and
long-term goals, create a plan and timeline to complete these goals, and the ability to track their
progress visually on an appealing graph. The journaling feature should allow for freewriting and
the option to choose from writing prompts. They would like to look back at past journal entries
that turn like a page in a book and the ability to customize the whole page with pictures, links, or
fonts. They would like a mood tracker to pop up when they click on any of the mindfulness
features; this pop-up should allow them to rate their mood by clicking on an emoji. The user
should be able to view a graph of their mood over time.
Additionally, the youth mentioned they would like the eHealth resource to have social
features that allow them to share pictures or video content with captions similar to the “Story”
feature on Instagram. Other ideas included: options to remain anonymous or to upload a profile
photo and to create their own avatar and username. They would like to view popular or famous
users’ profiles who have personal experiences and stories to tell about drug use, addiction, and
recovery. Finally, the focus group told us they would like the ability to call a helpline directly
from the app, to access information on local rehabilitation facilities, and to chat in real-time with
a live medical practitioner.
Youth Online Survey
An online survey was created to gain insight into our primary stakeholders and what they
were looking for in an eHealth drug resource. Specifically, what information to include in the
drug info guide and on the map view; how to present the information via text, illustration, video,
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and audio; and any other input they would like to contribute. The survey was distributed online
via social media from May 10-14, 2020, and inclusion criteria was anyone 12 years to 24 years
old residing in the United States.
There were 28 respondents. All of the respondents were within the desired age range,
with a fairly even distribution between 15 years and 23 years. Almost 90% of the respondents
self-identified as female, 7% identified as non-binary/third gender, and only one respondent selfidentified as male. Racial and ethnic data were not collected. Twenty out of 28 respondents lived
in California. The remainder lived in Maryland, Vermont, Massachusetts, Virginia, Rhode Island,
and Wisconsin.
Approximately 35% of respondents felt informed about drugs, their use, and their effects.
Almost 72% of respondents looked for or asked someone for information about drugs and their
effects. They searched the internet (7/28), YouTube (1/28), and social media (1/28), and they
asked their friends (9/28), peers at school (4/28), friends who use drugs (2/28), health teacher
(1/28), medical professional (1/28), and a parent (1/28).
The respondents wanted to know the following information about drugs, but were unsure
where to look or who to ask:
•

drug effects, short- and long-term (4/28);

•

how drugs affect the body and what it feels like (4/28);

•

drug use within the context of harm reduction (3/28);

•

dosages and potency (1/28); and

•

physiological effects of recreational drug use (1/28).
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The respondents reported the following fears related to drugs: addiction (75%), overdose
(75%), “bad trip” (60.7%), injury or death (57.1%), getting in trouble with authority figures/
parents (42.9%), peer pressure (32.1%), brain fog (3.6%), and nothing (3.6%).
Youth reported the following information as very important to include in the app:
duration of drug effects, short- and long-term side effects, interactions with other substances,
addictive nature, precautions and safety for use, and reversal agents/antidotes. The experience of
using the drug, photos of drugs, and common street names were important to include, and the
scientific names of drugs was not important to include in the app.
The most used substances among our respondents were, in order of usage: marijuana
(96.4%), alcohol (92.9%), tobacco (46.4%), cocaine (46.4%), hallucinogens (28.6%), and
prescription drugs (28.6%).
They have not found any drug- or alcohol-related resources particularly helpful or
informative (6/28). Two respondents felt their school health class was helpful. Two respondents
reported searching the internet is helpful. One respondent found the website Reddit informative
regarding stories about recovery from addiction.
Youth reported hearing about the news from family (85.7%), friends (82.1%), the
mainstream media (78.6%), Instagram (67.9%), teachers/other adults (46.4%), TikTok (39.3%),
Twitter (32.1%), Facebook (21.4%), Tonight with John Oliver (7.1%), and Wikipedia, Reddit,
LinkedIn, and email news subscriptions (3.6%).
Youth enjoyed learning about new things by talking with other people (96.4%), watching
shows/videos (57.1%), reading (46.4%), listening to audio books/podcasts (39.3%), interactive
activities (e.g., games, quizzes; 28.6%), and watching Tonight with John Oliver (7.1%).
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The respondents overwhelmingly use video- and photo-based apps the most, with Instagram and
TikTok tied for the most frequently used. They are also heavily into messaging, via native apps
and Facebook Messenger. Sixty-four percent downloaded a mindfulness or meditation app,
usually motivated by an existing need to manage stress or mental health or help with sleep.
Among social media accounts, there was a mix of relatable celebrities and aspirational
lifestyles, with a general theme of kookiness, approachability, and honesty. Overall, the tone of
the accounts was hopeful and confessional. Among the artistic accounts they follow, there was an
interesting mix of colorful, psychedelic imagery, as well as very simple black and white
illustration, often used in a narrative format, such as a comic. Many survey respondents showed a
strong affinity for brands that were sustainable, simple, clear, and also nostalgic. The aesthetic of
those sites was stark, high-contrast, and relied heavily on colorful products and photography for
liveliness.
Pilot Program
Invitations to participate in the GWConnect pilot program were sent via email in
February 2021 to the youth focus group participants, youth online survey respondents, Placer and
Nevada County high school students, and anyone under 25 years who was receiving services at
GWC. A personalized link to download the GWConnect app for pilot testing was emailed to
every respondent who completed the pre-pilot survey. The participants were given 80 days to
interface with the app and advised to provide feedback in the post-pilot survey.
The pre-pilot survey had 29 respondents, of which 65% resided in Placer County and
27% resided in Nevada County. The mean age was 17.5 years. Eighty-three percent identified as
female and 17% identified as male. All of the respondents had access to a mobile device, the vast
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majority (97%) with an Apple iOS operating system and a small minority (3%) with a Google
Android operating system.
The first question assessed the baseline level of knowledge about drugs, with a mean
score of 3.0, standard deviation of 0.87, and variance of 0.76. The second question assessed the
likelihood youth would use a mobile app to access information on drugs, with a mean score of
3.45, standard deviation of 1.00, and variance of 1.01. The third question assessed baseline
knowledge of drug treatment resources within their community and how to access them, with a
mean score of 2.21, standard deviation of 1.03, and variance of 1.06. The final question assessed
the likelihood youth would use a mobile app to access information on treatment resources in the
local area, with a baseline mean score of 3.72, standard deviation of 1.23, and variance of 1.51.
The post-pilot survey had only 12 respondents, which translates to a 41% completion rate
for the pilot program. Seventeen individuals were lost to follow-up, despite sending an email
with clear instructions explaining the pilot program process, multiple follow-up emails, and
offering an Amazon gift card as an incentive for completion. The mean age of the post-pilot
survey respondents was 20 years; 83% identified as female and 17% identified as male. Almost
two-thirds of the participants resided in Placer County and one-quarter resided in Nevada
County.
The post-pilot survey demonstrated a 26.47% increase in knowledge about drugs and a
20.32% increase in likelihood they would use a mobile app to access information on drugs.
Interestingly, even though the greatest increase was observed in knowledge of drug treatment
resources and how to access them (45.83%), there was only a slight increase in the likelihood
they would use a mobile app to access information on treatment resources (14.09%). Results of
the pre-pilot and post-pilot mean data are displayed in Table 1.
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Table 1
Survey Results
Survey
Pre-pilot mean
Post-pilot mean
% change

Q1
3.0
4.08
26.47

Q2
3.45
4.33
20.32

Q3
2.21
4.08
45.83

Q4
3.72
4.33
14.09

Note. Q denotes survey question number.

The level of importance that youth assigned to each app feature in the pre-pilot survey
correlated with the level of usefulness they reported for each feature in the post-pilot survey.
These findings indicate that the GWConnect team designed and developed each app feature to
suit the needs of the primary stakeholders. Results of the pre-pilot data are displayed in Figure 1,
and results of the post-pilot data are displayed in Figure 2.
Figure 1
Importance of Each App Feature
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Figure 2
Usefulness of Each App Feature

Overall, the pilot program participants were satisfied with the GWConnect app, with a
mean satisfaction score of 4.75, standard deviation of 0.83, and variance of 0.69. They found
GWConnect to be effective in providing information on drugs and local treatment resources,
with a mean effective score of 4.58, standard deviation of 0.86, and variance of 0.74. Suggested
improvements for the app included different colors, layout and navigation by adding more pages,
increase opportunities to interact with the app, and add more mindfulness features.
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Section V. Discussion
Summary
The aim of this project was to design and develop an eHealth drug resource that provided
culturally-informed harm reduction tools, including unbiased drug information and treatment
resources, to reduce the overall prevalence of SUD/OUD among rural youth. A pilot program
was conducted to determine if the app was effective in delivering evidence-based information on
drug and local treatment resources, if youth were satisfied with the app, and if access to the app
for up to 80 days resulted in increased knowledge of drugs and treatment resources. The longterm overarching aim of this project is, by increasing access to this information in a format
familiar to youth, they will make informed health decisions and seek out help when they need it,
thereby reducing the incidence of OUD and deleterious health outcomes, such as overdoses.
Data were collected from youth via an in-person focus group and an online survey in
order to determine what youth were looking for in an eHealth drug resource. That data informed
the design and development of GWConnect. Key findings from the focus group included a
significant emphasis on harm reduction principles and language, unbiased drug information,
preference towards pictures over words, and the importance of mindfulness features, such as
meditations. The online survey informed the team that youth wanted access to the following
information, but were unsure where to look or who to ask: short- and long-term drug effects, how
drugs affect the body and what it feels like, drug use within the context of harm reduction,
dosages and potency, and the physiological effects of recreational drug use.
Interpretation
The anticipated outcomes of this project included designing and developing an eHealth
resource based upon harm reduction principles that would engage youth and result in increased
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knowledge of drugs and treatment resources after an 80-day pilot program. Cordova et al. (2020)
found that mHealth technology can be used to prevent and reduce health risk behaviors (e.g.,
substance use and unsafe sexual practices) among adolescents. Scheier et al. (2019) gathered
stakeholder input on the design of an online drug prevention program, and the key findings were
that the drug prevention content should be presented in an interactive and engaging manner.
Mobile health resources have been found to engage youth in preventing health risk behaviors,
specifically drug use (Cordova et al., 2018). The findings of this project are comparative to
findings from other researchers.
The youth focus group and online survey data informed the design and development of
GWConnect. GWConnect was built with four main sections: Home, Information (Info), Help,
and Map. Advanced nurse practitioners are particularly well-suited for translating the evidencebased literature for practical application. Therefore, based upon the data collected, the DNP
student built the evidence-based drug data set for the Info section of the app, utilizing harm
reduction principles without any particular persuasion towards abstinence, including pictures of
the drugs in their various forms from the FDA picture database. Commonly abused drugs, such
as opioids, hallucinogens, stimulants, depressants, and inhalants, were included, and information
on commercial uses, street names, common forms, short-term effects, long-term effects, healthrelated issues, outcomes of mixing with alcohol, and withdrawal symptoms was provided.
The Home page is the main page, which includes a “How to use naloxone” video that the
DNP student researched and uploaded. The DNP student, sensitive to primary stakeholder needs,
also researched and recorded a 6-minute body scan meditation that is accessible on the Home
page. The Help section offers an opportunity to ask anonymous questions related to substances
and substance use, and a GWC clinician will provide an answer. The question and corresponding
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answer will be published for any user to view and reference for their own benefit. The final
section of the app is a Google maps that has pinned locations for all of the local treatment
resources in Nevada and Placer Counties.
Prior to the pilot program, an online survey collected baseline data. Of note, 100% of
respondents reported having access to a mobile device with either an Apple or Google Android
operating system. The respondents felt moderately knowledgeable about drugs and slightly
knowledgeable about treatment resources. They reported being somewhat likely to use a mobile
app to access information on both drugs and treatment resources. They ranked the app features as
follows, from most to least important: drug facts and figures, warnings related to drug use in the
local community (e.g., uptick in fentanyl overdoses), ability to chat with and ask a medical
provider questions, treatment resources, mindfulness activities, education on Narcan, and Q&A
forum.
The pilot program consisted of a personalized link to download the GWConnect app. The
participants were given 80 days to interface with the app and advised to provide feedback in the
post-pilot survey. The post-pilot survey demonstrated a 26.47% increase in knowledge about
drugs and a 45.83% increase in knowledge of treatment resources. One of the most notable
findings was that the level of importance youth assigned to each app feature in the pre-pilot
survey correlated with the level of usefulness they reported for each feature in the post-pilot
survey. These findings indicated that the GWConnect team designed and developed each app
feature to suit the needs of the primary stakeholders.
Overall, the pilot program participants were satisfied with the GWConnect app, and they
found it to be very effective in providing information on drugs and local treatment resources.
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GWConnect will be published to the Apple and Google app stores as a free download. A
longitudinal study is recommended to assess app effectiveness related to health risk behaviors,
specifically substance use and SUDs, among youth.
Limitations
The major limitation of this project was the small sample size of participants who
completed the pilot program. The pre-pilot survey had 29 respondents; however, the post-pilot
survey had only 12 respondents, which translates to a 41% completion rate for the pilot program.
Seventeen individuals, accounting for 59% of initial respondents, were lost to follow-up, despite
sending an email with clear instructions explaining the pilot program process, multiple follow-up
emails, and offering an Amazon gift card as an incentive for completion.
Greater than 20% loss to follow-up threatens the validity of the study results (Dettori,
2011). The various reasons 59% of respondents did not complete the pilot program, albeit
unknown, can lead to bias among the final results. There is potential that only respondents who
were satisfied with the app completed the program; whereas, those who were dissatisfied with
the app did not complete the program.
Interestingly, the vast majority of the pilot program participants were female. There are
higher rates of substance use among males versus females; therefore, the gender distribution of
the sample size is not representative of substance use among the general population (National
Institute on Drug Abuse, 2021). Follow-up studies with larger sample sizes, more representative
of the larger population, and more robust follow-up protocols can minimize and adjust for this
limitation.
Another expected limitation is related is that GWConnect was designed specifically for
youth 12 years to 24 years old in Nevada and Placer Counties. As a result, the findings of the

DEVELOPMENT OF AN EHEALTH HARM REDUCTION RESOURCE

59

pilot program are not generalizable to a larger population. GWConnect will be available for
anyone to download from the Apple and Google stores; however, future research is needed to
assess its effectiveness among youth in other geographic locations.
There were only modest increases in the scores related to the likelihood youth would use
the mobile app to access information on drugs and treatment resources, indicating room for
improvement in the app. However, the respondents offered few suggestions for improvement.
Suggested improvements included changing the colors, increasing the app interactivity,
improving the layout and usability by adding pages or tabs, and adding more mindfulness
features.
The final barrier to implementation is publishing GWConnect to the Apple and Google
app stores. The app developer will submit GWConnect to the app stores for review, with the
required fees, and upon approval, the app will be published for free download.
Conclusions
Opioid use/misuse is a leading cause of injury and death among adolescents and young
adults in the United States (Hudgins et al., 2019). Opioid misuse also correlates with misuse of
other substances, which exponentially increases health risks over time. The most effective
treatment for OUD among adolescence is through effective prevention interventions that either
preclude the development of the OUD or enable timely diagnosis and treatment in order to
prevent poor health outcomes. eHealth technologies have been shown to effectively prevent and
treat other chronic diseases, and recent research has reported results supporting the use of
eHealth technologies to prevent and/or treat SUDs among youth (Cordova et al., 2018, 2019,
2020; Nuamah et al., 2020).
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Designing and developing eHealth technologies specifically for the management of OUD
could eliminate a barrier to MAT treatment by allowing the patient the ability to communicate
with a medical provider, track his or her symptoms, and access evidence-based information and
reliable resources related to OUD. This technology could be particularly useful among youth due
to their familiarity with and affinity towards using technology in their everyday lives.
The pilot program of the eHealth technology, GWConnect, designed and developed in
this project, found the app to be effective in increasing youth knowledge of drugs and treatment
resources in their local area and effective in increasing their likelihood of using the app to access
the aforementioned information. Youth also reported high levels of satisfaction and app
effectiveness in delivering the information it set out to deliver. GWConnect will now be
submitted for publication to the Google and Apple app stores as a free download.
The app was built upon harm reduction, rather than the traditional abstinence-only
prevention, since research has shown these principles are the most relevant to today’s youth
(Jenkins et al., 2017). Increased knowledge can empower youth to make informed decisions
preventing SUD and/or reducing harm related to risky behaviors. Increased knowledge of
treatment resources can improve timeliness of treatment initiation and reduce harm associated
with untreated SUD.
The overarching aim of GWConnect is to reduce the incidence of OUD and overdose
among rural youth in Northern California; therefore, future longitudinal research is needed to
assess its effectiveness over a period of time. User data from Google and Apple can also be
utilized to drive future updates and potentially inform the development of an app that would be
relevant and applicable to a broader audience.
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Appendix A. Johns Hopkins Nurse Evidence-Based Evaluation Table
Citation

Purpose

Research Design

Methodology

Findings

Conclusion

Cordova et
al., 2018

Assessed the
usability and
acceptability of a
mobile health
(mHealth) app
among
adolescents and
its effect on health
risk behaviors,
specifically drug
use, condomless
sex, and STI/HIV
testing.

Multiple-methods
approach.
Purposive sampling
of 30 adolescents
(13-22 years),
predominantly
African American
and female, in
Southeast
Michigan.
Quantitative and
qualitative usage
data of a mHealth
resource was
collected from July
to September 2015.

An mHealth
preventive
intervention was
designed in
collaboration with a
Youth Leadership
Council. The
adolescents were
asked to fill out a
demographics
questionnaire and
health risk behavior
assessment
questionnaire, test
the mHealth
resource on iPads,
complete modules
to assess usability,
and participate in
either a focus group
or individual
interview to discuss
the overall
experience.

Pre-assessment data
revealed that 36%
of adolescents selfreported illicit drug
use within the past
90 days, and 71%
of adolescents selfreported engaging
in sexual activity
within the past 90
days. Postassessment data
revealed
adolescents
reported high levels
of usability and
acceptability of the
mHealth
intervention.

Adolescents found
that the online risk
assessment was a
great way to initiate
a conversation
about sensitive
subjects related to
health risk
behaviors with their
medical provider.
The mHealth
resource provided
access to
information on
drugs that
adolescents found
to be helpful,
increased their
knowledge, and
gave them tools to
use in order to
make informed
decisions. Overall,
adolescents found
the mHealth
resource to be
helpful in engaging
them in preventing
health risk
behaviors,

Critical
Appraisal
Tool &
Rating
Level III
Good Quality
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Citation

Purpose

Research Design

Cordova et
al., 2019

Assessed
feasibility and
accessibility of
Storytelling 4
Empowerment, a
mobile app
aiming to prevent
substance use and
STI/HIV.

This multi-method
study design
utilized
community- based
participatory
research principles
(CBPR) to engage
both medical
clinicians and
youth.

Cordova et
al., 2020

Mobile health
(mHealth)
technology can be
used to prevent
and reduce health
risk behaviors
(e.g., substance
use and unsafe
sexual practices)
among
adolescents.

Scheier et al.,
2019

Assessed
stakeholder input
on the design of
an online familybased drug
prevention

Storytelling 4
Empowerment
(S4E) was
evaluated for its
effect on health
behavior change
among youth. S4E
consists of three
interactive online
modules on alcohol
and drug use, and
STI/HIV.
This mixedmethods study was
a Phase I
NIH-funded Small
Business Innovative
Research grant. The

Methodology

71
Findings

Conclusion

specifically related
to drug use and
sexual practices.
High levels of
feasibility and
accessibility were
reported by both the
clinicians and the
youth.

Critical
Appraisal
Tool &
Rating

The use of S4E was
evaluated among
medical clinicians
and youth focusing
on improving the
communication
between them, as
well as reducing
health risk
behaviors among
youth.
50 youth (13-21
years) were
randomized to
either the S4E arm
or the standard care
arm with a preassessment, postassessment, and 30day postassessment.

The data suggested
that S4E facilitated
communication
between youth and
clinicians, as well
as prevention
approaches.

Level III
Good Quality

Youth in the S4E
arm demonstrated a
reduction in health
risk behavior over
the past 30 days,
including substance
use, as well
increased
knowledge of
prevention
strategies.

mHealth
technology can be
utilized to reduce
substance use and
other health risk
behavior among
youth.

Level I
Good Quality

They conducted
interviews with
prevention and
online learning
experts and family
services personnel.

The principal
findings revealed
that the online
program should
include the drug
prevention content

This study informed
the design and
development of
curriculum for an
online family-based
drug prevention

Level III
Good Quality
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SchumanOlivier et al.,
2018
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Purpose

Research Design

Methodology

Findings

Conclusion

program called
Strengthening
Families Program
(SFP). The inperson format has
proven to be
effective in
preventing youth
drug and alcohol
use, but that
delivery method
requires a lot of
resources.

study engaged
subject-matter
experts and
stakeholders in the
design of the online
SFP.

They also surveyed
and conducted 10
focus groups with
85 adults.

program based
upon what the
family wants to
learn, in the
preferred delivery
format, and with
features that
facilitate
engagement and
retention.

Assessed the
feasibility,
usability, and
acceptability of
MySafeRx, a
mobile resource
developed to
promote
buprenorphine/
naloxone
treatment
adherence.

28-day single-arm
observational study
of use of MySafeRx
resource among
early adults (18-39
years) receiving
buprenorphine/
naloxone for
treatment of opioid
use disorder.

The MySafeRx
technology
incorporates
motivational
mentorship, ability
to message your
medical provider,
and medication
monitoring.

in an interactive
and engaging
manner.
There was an
emphasis placed on
brief skills-oriented
sessions, graphics
over text,
animation, real-life
role play scenarios,
connection with
agency personnel
who can monitor
progress, and
printable materials
to work on at home.
Illicit opioid
abstinence
increased by 53%
during the 28-day
trial period.
Participants
reported good
levels of usability
and acceptability of
the MySafeRx
technology.

The MySafeRx, or
other similar mobile
technology, can be
used to increase
adherence to opioid
use disorder
treatment.

Critical
Appraisal
Tool &
Rating

Level III
Good Quality
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Appendix B. Gap Analysis
Gap Analysis
Project
Name

Development of an eHealth Harm Reduction Resource to Address Opioid Use Among Youth in
Rural Northern California

Date
Project
Aim

May 2021
The overarching aim is to reduce the incidence of OUD and OD among rural youth in Northern
California. The project goal is the development and implementation of an eHealth intervention by
May 2021 that will provide culturally-informed harm reduction tools (e.g., unbiased drug
information, Narcan information, news alerts, “ask a provider” feature, and referral resources to
reduce the prevalence of SUD/OUD among rural youth.
Current State
Best Practice
Proposed Solution
Limited knowledge of evidencebased information on drugs and
available treatment resources
resulting in an underserved
adolescent population with or atrisk of developing an OUD.

Access to evidence-based
information on drugs and available
treatment resources within a rural
Northern California community in
order to improve knowledge about
drugs and use/misuse, as well as
awareness of and how to access the
available treatment resources within
the local area.

Design and develop an eHealth
drug resource specifically for the
adolescent population within this
rural Northern California
community, publish it to the Google
and Apple store for free download,
and incorporate it into treatment
protocols for youth with OUD at
Granite Wellness.
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Appendix D. Work Breakdown Structure
1.0 Design
1.1 Develop Project Scope
1.2 Gap Analysis
1.3 Develop Objectives
1.4 Identify Key Stakeholders
1.5 Develop Project Charter
1.6 Submit Project Charter
2.0 Plan
2.1 Identify Project Team
2.2 Discussion of Roles
2.3 Develop Project Plan
2.4 Develop WBS
2.5 Develop Focus Group Questionnaire Surveys
3.0 Intervention
3.1 Conduct Focus Group
3.2 Conduct Online Survey
3.3 Design & Develop Granite Connects App
3.3.1 Build Evidence-based Drug Data Set
3.3.1.1 Research
3.3.1.2 Consult with Personnel Familiar with Harm Reduction Principles
3.3.2 Record Guided Body Scan
3.4 Pilot Program
3.4.1 Administer Pre- and Post-testing Surveys
4.0 Results
4.1 Analyze Survey Findings
4.1.1 Summarize Findings and Write Recommendations
5.0 Evaluation
5.1 Review Survey Feedback
5.2 Write Final Report
5.3 Dissemination
5.3.1 DNP Paper
5.3.2 DNP Presentation
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Appendix E. Communication Matrix

Information

Audience

When

Communication
Method
Email, Zoom,
Dashboard, Slack

DNP project
development,
implementation, and
status updates
DNP project
milestones and
revisions
DNP project hurdles

DNP Chair,
GWConnect team

Weekly

DNP Chair and
Committee Member

Monthly

Email, Zoom

DNP Chair

As needed

Email, Zoom
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Appendix F. SWOT Analysis

STRENGTHS
•
•

•
•

•
•
•
•

•

The vast majority of youth are familiar with and
have ready access to mobile technologies.
Youth usually have some sort of mobile
technology with them most of the time making a
mobile app an ideal intervention to use in this
population.
Mobile technologies have been successfully used
to prevent and manage other chronic diseases.
During the COVID-19 pandemic, people have
become more reliant on mobile technologies to
connect virtually due to limitations on in-person
interactions.
Increased knowledge can facilitate informed
decision making during youth that can prevent
opioid use disorder.
App design and development based upon
primary stakeholder data obtained via focus
group and online survey.
The app is designed and developed for youth 1224 years in Nevada and Placer Counties
Funding through the YOR CA grant.
Buy-in by the GWC administration.

OPPORTUNITIES
•
•

•
•
•

•

•

Initial research revealed that there is not a
comparable app on the market currently.
Primary stakeholders reported what they were
looking for in an eHealth resource through the
focus group and online survey, and that data
gave the team the opportunity to design and
develop the app specifically for the primary
stakeholders.
Opportunity to connect with youth in a medium
that they prefer, are familiar with, and have
ready access to.
Ability to remain connected with youth even
during the COVID-19 pandemic when in-person
interactions are limited.
Youth will have the opportunity to access
evidenced-based information on drugs,
treatment resources, and ask a medical provider
questions in a secure, confidential, and nonconfrontational manner.
Dispel common myths about drugs and drug
use.
Prevent OUD amongst youth in Northern
California.

WEAKNESSES
•

•
•

•
•
•

The app is designed and developed for youth 1224 years in Nevada and Placer Counties; Youth
in other Counties may not find it applicable to
them.
Ability to get youth to download and use the
app.
The app requires a medical provider to answer
any questions that are asked requiring frequent
monitoring of the app in order to provide a
response in a timely manner.
The app requires updates regarding news
related to drugs, use, and warnings in the local
area.
The app will require updates to remain
compatible with Android and iOS operating
systems.
Cost of maintaining and updating the app over
time.

THREATS
•
•

•

•

App buy-in by youth.
Youth may have a fear that their
parents/guardians or the app administrator(s)
are monitoring their activity, and simply
accessing drug information could be perceived
as thinking about or actually using drugs.
Parents/guardians having a misperception that
allowing youth to access information will make
them more apt to use drugs.
Concern that the YOR CA grant funding may
not be renewed.
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Appendix G. 3-Year Proforma
Design, Development, Distribution, and
Maintenance of GWConnect
Year 1
Grant Funding
Deductions from Revenue

Total revenue

Year 2

Year 3

$500,000 $515,000 $530,450
0

0

$500,000 $515,000

0

$530,450

NP wages (0.5 NP FTE)

$56,737

$58,439

$60,192

App Design & Development
(0.5 App Developer FTE in Years 2 & 3)

$25,000

$36,987

$38,096

Total wages

$81,737

$95,426

$98,288

$100

$103

$106

Total Expenses

$81,837

$95,529

$98,394

Revenue less expenses

$418,163 $419,471 $432,056

Supplies

DEVELOPMENT OF AN EHEALTH HARM REDUCTION RESOURCE
Appendix H. Return on Investment Analysis
Cost of GWConnect App

Cost Savings/Avoided
Expenses

Balance

($81,837)

$1.3 million per fatal
overdose
$176.8 million fatal
overdoses per day

$1.2 million

($81,837)

$176.7 million
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